Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Grunenthal GmbH et al. Post grant review
Case Number:
Case Type:
PGR
Status:
Final Written Decision
Petitioner:
Grunenthal GmbH et al.
Patent Owner:
Tech Center:
-
July 30, 2020
PTAB Axes Antecip IP, Rejects Its Printed Publication Stance
The Patent Trial and Appeal Board has invalidated three Antecip Bioventures pain treatment patents, shooting down its argument that German rival Grunenthal GmbH didn't do enough at the institution stage to prove that five printed publications qualify as prior art.
-
April 24, 2020
Patent Owner's Printed Publication Stance Riles PTAB Judge
A Patent Trial and Appeal Board judge bristled Friday at an argument from Antecip Bioventures that more evidence is required from petitioners at the institution stage to prove the public accessibility of prior art printed publications, contrary to the board's seven-year practice.